13:25 EST Evolus (EOLS) trading halted, news pending
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EOLS:
- Evolus price target raised to $22 from $20 at Barclays
- TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
- Evolus sees FY25 revenue $345M-$355M, consensus $347.37M
- Evolus expects FDA approval for Evolysse within 90 days, ahead of schedule
- Evolus reports preliminary Q4 revenue $79M, consensus $77.23M